NEW YORK, March 7, 2016 /PRNewswire/ -- The Law
Offices of Vincent Wong announce
that a class action lawsuit has been commenced in the USDC for the
Southern District of New York on
behalf of investors who purchased GW Pharmaceuticals plc (Nasdaq:
GWPH) securities between December 4,
2014 and January 8, 2016.
Click here to learn about the case:
http://docs.wongesq.com/GWPH-Info-Request-Form-1080. There
is no cost or obligation to you.
The complaint alleges that throughout the Class Period,
defendants made false and/or misleading statements and/or failed to
disclose that: (i) the Company lacked effective internal financial
controls; (ii) the Company lacked effective controls over
completeness and valuation of clinical trial accruals; and (iii) as
a result of the foregoing, Defendants' statements about GW
Pharmaceuticals' business, operations, and prospects were false and
misleading and/or lacked a reasonable basis.
In its 2015 Annual Report, GW Pharmaceuticals disclosed the
discovery of a material weakness in its internal control over
financial reporting for the year ended September 30, 2015. The Company noted that
"management does not have sufficiently precise controls to evaluate
the completeness and accuracy of the calculation of clinical trial
accruals due to the incorrect allocation of expenditure to clinical
studies." On this news, GW Pharmaceuticals stock fell $3.55, or nearly 6%, to close at $56.31 per share on January 11, 2016.
If you suffered a loss in GW Pharmaceuticals you have until
March 21, 2016 to request that
the Court appoint you as lead plaintiff. Your ability to share in
any recovery doesn't require that you serve as a lead plaintiff. To
obtain additional information, contact Vincent Wong, Esq. either via email
vw@wongesq.com, by telephone at 212.425.1140, or visit
http://docs.wongesq.com/GWPH-Info-Request-Form-1080.
Vincent Wong, Esq. is an
experienced attorney that has represented investors in securities
litigation involving financial fraud and violations of shareholder
rights. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
Logo - http://photos.prnewswire.com/prnh/20140904/143045
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-the-law-offices-of-vincent-wong-notify-investors-of-class-action-lawsuit-involving-gw-pharmaceuticals-plc-and-a-lead-plaintiff-deadline-of-march-21-2016---gwph-300231682.html
SOURCE The Law Offices of Vincent
Wong